Signatur Biosciences

New York, United States

Signatur Biosciences is a biotech company that offers bringing molecular diagnostics services for cancer patients.

$7.0M raised

Apr 2025

Seed

Biopharma Biotechnology Medical Device

Top Investors

Y CombinatorIon Beam ApplicationsNoshaq

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Signatur Biosciences

How much funding has Signatur Biosciences raised?

Signatur Biosciences has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in April 2025.

Who are Signatur Biosciences's investors?

Signatur Biosciences's investors include Y Combinator, Ion Beam Applications, Noshaq.

Where is Signatur Biosciences headquartered?

Signatur Biosciences is headquartered in New York, United States.

What does Signatur Biosciences do?

Signatur Biosciences is a biotech company that offers bringing molecular diagnostics services for cancer patients.

What stage is Signatur Biosciences at?

Signatur Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2025.

MLA

"Signatur Biosciences — Funding & Investors." VCBacked, April 28, 2025, https://www.vcbacked.co/company/signatur-biosciences. Accessed June 9, 2026.

APA

VCBacked. (2025). Signatur Biosciences — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/signatur-biosciences

Wikipedia (cite web)

{{cite web |title=Signatur Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/signatur-biosciences |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2025.

Similar Companies in Biopharma